JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 15, 2008; DOI: 10.1124/jpet.108.143677


0022-3565/08/3273-934-940$20.00
JPET 327:934-940, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.143677v1
327/3/934    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oda, M.
Right arrow Articles by Sakurai, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oda, M.
Right arrow Articles by Sakurai, J.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Effect of Erythromycin on Biological Activities Induced by Clostridium perfringens {alpha}-Toxin

Masataka Oda, Atsushi Kihara, Hiroki Yoshioka, Yuki Saito, Naoyuki Watanabe, Kana Uoo, Masahiro Higashihara, Masahiro Nagahama, Naoki Koide, Takashi Yokochi, and Jun Sakurai

Department of Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, Japan (M.O., A.K., H.Y., Y.S., N.W., K.U., M.H., M.N., J.S.); and Department of Microbiology and Immunology, Aichi Medical University, School of Medicine, Nagakute, Aichi, Japan (N.K., T.Y.)

Clostridium perfringens {alpha}-toxin, an important agent of gas gangrene with inflammatory myopathies, possesses lethal, hemolytic, and necrotic activities. Here, we show that {alpha}-toxin-induced lethality in mice was inhibited by i.v. preadministration of erythromycin (ERM). Administration of ERM resulted in a drastic reduction in the release of tumor necrosis factor (TNF)-{alpha}, interleukin (IL)-1β, and IL-6 and systemic hemolysis induced by {alpha}-toxin, whereas the administration of kitasamycin did not. Furthermore, the lethality and systemic hemolysis caused by {alpha}-toxin were blocked by the preinjection of anti-TNF-{alpha}, but not the anti-IL-1β- or anti-IL-6-antibody. In addition, TNF-{alpha}-deficient mice were resistant to {alpha}-toxin, indicating that TNF-{alpha} plays an important role in the lethality. ERM inhibited the toxin-induced release of TNF-{alpha} from neutrophils and phosphorylation of toropomyosin-related kinase receptor A (TrkA) and extracellular-regulated kinase (ERK) 1/2. Furthermore, K252a, a TrkA inhibitor, and PD98059 (2'-amino-3'-methoxyflavone), an ERK1/2 inhibitor, inhibited the toxin-induced release of TNF-{alpha} from neutrophils. The observation shows that the toxin-induced release of TNF-{alpha} is dependent on the activation of ERK/mitogen-activated protein kinase signal transduction via TrkA in neutrophils and that ERM specifically blocks the toxin-induced events through the activation of neutrophils.


Received July 20, 2008; accepted September 12, 2008.

Address correspondence to: Dr. Jun Sakurai, Department of Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashirocho, Tokushima 770-8514, Japan. E-mail: sakurai{at}ph.bunri-u.ac.jp







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.